sábado, 13 de junio de 2020

Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement | NLM

Disaster Information Management Research Center | NLM

Disaster Information and Emergency Response

05/01/2020 12:00 AM EDT


Source: RAND Corporation. Published: 5/2020. This 15-page report discusses the need for more sustainable and scalable ways of incentivising pharmaceutical industry innovation in response to infectious disease threats to public health. The authors consider incentives for innovation both in the current context of the COVID-19 crisis, and in the context of preventing other emerging or re-emerging infectious disease threats from becoming crises further down the line. (PDF)

No hay comentarios: